Expression of Biofilm-Related Genes in Extensively Drug-Resistant Acinetobacter baumannii

被引:1
|
作者
Khosravy, Maryam [1 ]
Hosseini, Farzaneh [2 ]
Razavi, Mohamad Reza [3 ]
Khavari, Ramazan Ali [1 ]
机构
[1] Islamic Azad Univ, Dept Biol, Sci & Res Branch, Tehran, Iran
[2] Islamic Azad Univ, Dept Biol, North Tehran Branch, Tehran, Iran
[3] Pasteur Inst Iran, Mol Parasitol Lab, Tehran, Iran
关键词
Acinetobacter baumannii; Pneumonia; Biofilm; XDR; IDENTIFICATION; INFECTION; PRODUCTS; STRAINS;
D O I
10.5812/jjm-133999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Acinetobacter baumannii is an important cause of nosocomial pneumonia in patients requiring long-term mechanical ventilation. Besides, extensively drug-resistant (XDR) strains cause infection in intensive care unit (ICU) patients. Chronic infections of A. baumannii and antimicrobial resistance are associated with biofilm formation. Several virulence genes, such as blaPER-1, pgaA, and bap, are involved in biofilm formation. Objectives: The current study examines the expression levels of biofilm formation-related genes in pneumonia patients. Methods: The sputum samples were collected from patients hospitalized in the ICU, and A. baumannii ATCC 19606, the reference strain, was isolated and cultured on blood agar, eosin methylene blue agar, and chocolate agar medium. The media were then incubated at 37 & DEG;C for 18 -24 hours. Next, Gram-Thirty XDR A. baumannii isolates were collected from the sputum samples of ICU patients at Besat Hospital in Tehran, Iran. Bacterial isolates were characterized for antibiotic resistance patterns and biofilm-forming ability. Subsequently, RNA was extracted from the biofilm-forming isolates. A real-time polymerase chain reaction (PCR) assay was performed to evaluate the expression levels of the blaPER-1, pgaA, and bap genes. Transcripts were normalized to 16S rRNA as an internal control, and gene expression fold changes were calculated. Statistical analysis was performed using an unpaired two-tailed t-test (P < 0.05) with SPSS (V. 16). Results: The disk diffusion susceptibility test revealed that all 30 (100%) isolates were resistant to piperacillin-tazobactam, cefepime, ceftriaxone, ceftazidime, gentamicin, imipenem, meropenem, levofloxacin, and ciprofloxacin. All 30 isolates from ICU-admitted patients (100%) were classified as XDR, and 27 (90%) isolates demonstrated the ability to form biofilms. The obtained results indicated a significant difference in gene expression levels. The fold change in expression for blaPER-1, bap, and pgaA was 7.473, 11.964, and 5.277, respectively. Conclusions: In our study, XDR A. baumannii primarily caused ventilator-associated pneumonia, and an observed increase in the expression of biofilm-related genes was noted in these strains. Healthcare centers should implement appropriate infection control programs to manage nosocomial infections, particularly in the ICU.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Epidemiological characteristics and antimicrobial resistance of extensively drug-resistant Acinetobacter baumannii in ICU wards
    Shi, Jingchao
    Mao, Xiaoting
    Sun, Fengtian
    Cheng, Jianghao
    Shao, Lijia
    Shan, Xiaoyun
    Zhu, Yijun
    MICROBIOLOGY SPECTRUM, 2025, 13 (04)
  • [22] High frequency of carbapenemase in extensively drug-resistant Acinetobacter baumannii isolates in central Iran
    Abbasi, Elnaz
    van Belkum, Alex
    Ghaznavi-Rad, Ehsanollah
    WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, 2023, 39 (11):
  • [23] Treatment of Intracranial Infection by Extensively Drug-Resistant Acinetobacter Baumannii After Craniocerebral Surgery
    Xiong, Xuan
    Xie, Yu
    Li, Bujun
    Yin, Caixia
    Hu, Kai
    JOURNAL OF CRANIOFACIAL SURGERY, 2024, 35 (07) : e673 - e675
  • [24] High frequency of carbapenemase in extensively drug-resistant Acinetobacter baumannii isolates in central Iran
    Elnaz Abbasi
    Alex van Belkum
    Ehsanollah Ghaznavi-Rad
    World Journal of Microbiology and Biotechnology, 2023, 39
  • [25] "Excess Mortality" and Colistin-Tigecycline for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia
    Poulakou, Garyphallia
    Bassetti, Matteo
    Tsiodras, Sotirios
    CRITICAL CARE MEDICINE, 2015, 43 (10) : E470 - E471
  • [26] Investigations on Acinetophage, QAB 3.4, Targeting Extensively Drug-Resistant Acinetobacter baumannii Isolates
    Hussain, Aamir
    Kousar, Shaheena
    Ullah, Ihsan
    Zulfiqar, Aqsa
    Ali, Hafiz Arslan
    Manzoor, Amina
    Aziz, Atif
    Javaid, Asghar
    Aziz, Mubashar
    Khaliq, Binish
    Nazir, Humera
    Khan, Aleem Ahmed
    Akrem, Ahmed
    Saeed, Muhammad Qamar
    INFECTION AND DRUG RESISTANCE, 2021, 14 : 4261 - 4269
  • [27] Fatal Outbreak of an Emerging Clone of Extensively Drug-Resistant Acinetobacter baumannii With Enhanced Virulence
    Jones, Crystal L.
    Clancy, Megan
    Honnold, Cary
    Singh, Shweta
    Snesrud, Erik
    Onmus-Leone, Fatma
    McGann, Patrick
    Ong, Ana C.
    Kwak, Yoon
    Waterman, Paige
    Zurawski, Daniel V.
    Clifford, Robert J.
    Lesho, Emil
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (02) : 145 - 154
  • [28] Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates
    Trebosc, Vincent
    Gartenmann, Sarah
    Totzl, Marcus
    Lucchini, Valentina
    Schellhorn, Birgit
    Pieren, Michel
    Lociuro, Sergio
    Gitzinger, Marc
    Tigges, Marcel
    Bumann, Dirk
    Kemmer, Christian
    MBIO, 2019, 10 (04):
  • [29] Risk factors and predictive model for nosocomial infections by extensively drug-resistant Acinetobacter baumannii
    Shi, Jingchao
    Mao, Xiaoting
    Cheng, Jianghao
    Shao, Lijia
    Shan, Xiaoyun
    Zhu, Yijun
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [30] First detection of a cefiderocol-resistant and extensively drug-resistant Acinetobacter baumannii clinical isolate in Bulgaria
    Strateva, Tanya
    Peykov, Slavil
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2024, 71 (01)